THE LATEST WORD

Top Industry Stories – May 26, 2010

Posted on May 26th, 2010 | by Rxmedyn | No Comments »

FDA Probes Hundreds of Problems With J&J Medicines

Hep C Drug Achieves 75 Percent Cure Rate: Study

FDA Warns of Bone Fracture With Heartburn Drugs

Study Finds Supplements Contain Contaminants

For Pharmas, Online Video, Ad Exchanges Are The Future (For Everybody Else, They’re The Present)

Posted in Industry Stories

Top Industry Stories – May 24, 2010

Posted on May 24th, 2010 | by Rxmedyn | No Comments »

Art Therapy Reduces Anxiety in Kids with Asthma

Many Vaccines at Once OK For Kids’ Brains: Study

GE Spent $700 Million on R&D in First Year of Health Initiative

Abdi Ibrahim in Talks With U.S., European Drugmakers

Global Death Rates Drop for Children 5 or Younger

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – May 21, 2010

Posted on May 21st, 2010 | by Rxmedyn | No Comments »

New Estimate Says Health Plan to Cost Ind. $2.9B

Researchers Say They Created a ‘Synthetic Cell’

When Patients Don’t Fill Their Prescriptions

FDA Details New Transparency Plans

Posted in Industry Stories

Top Industry Stories – May 20, 2010

Posted on May 20th, 2010 | by Rxmedyn | No Comments »

German Court Overturns Glaxo’s Patent on Advair

French Authorities to Investigate Sanofi

Sonic Healthcare Issues First Profit Warning on Subsidy Cuts

Novartis Fined $250 Million in Sex Discrimination Suit

Teva Gets OK To Market Generic Lipitor in Canada

Posted in Industry Stories

Top Industry Stories – May 19, 2010

Posted on May 19th, 2010 | by Rxmedyn | No Comments »

FDA Urged To Make Public More Company Data

Prescription Drug Use By U.S. Children On Rise: Medco

Pfizer’s Generics Unit Has Need For Speed

Medco Makes Push Into Genetic Tests

J&J Details Medicine-Recall Troubles

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – May 17, 2010

Posted on May 17th, 2010 | by Rxmedyn | No Comments »

Astellas Raises Offer for OSI Pharma to $4 Billion

Does Eating Too Much Lead to Urinary Incontinence?

FDA Urges Doctors To Report Misleading Drug Ads

Eisai Debuts Online Resource for Cancer Nurses

Glaxo, Merck Vaccines OK Despite Pig Virus-U.S. FDA

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – May 12, 2010

Posted on May 12th, 2010 | by Rxmedyn | No Comments »

FDA To Look Into Gene Tests to be Sold at Walgreens

Infections Cause 68 pct of Child Deaths, Study Finds

FDA Urges Docs to Report Misleading Drug Ads

AstraZeneca Case Rewards Repeat Whistleblowers With $45 Million

 New Help to Free Legs From a Web

Posted in Industry Stories

Top Industry Stories – May 11, 2010

Posted on May 11th, 2010 | by Rxmedyn | No Comments »

Obesity Task Force Urges Action

U.S. Group Urges FDA to Halt Glaxo’s Avandia Trial

Health Overhaul Law Potentially Costs $115B More

First Lady Releases Child Obesity Recommendations

Merck: Schering-Plough Integration is on Track

How’s My Detailing? Dial 1-877-RX-DDMAC

Consumers Want Unbranded Sites, Despite FDA Warnings

Posted in Uncategorized

Top Industry Stories – May 6, 2010

Posted on May 6th, 2010 | by Rxmedyn | No Comments »

Congress Probing J&J Children’s Tylenol Recall

Surgery “Should Be Last Resort for Obese Children”

Goldman Gets 235-Fold Return on Hepalink in Stock Trading Debut

Will Premiums Fall for the Middle Class?

Posted in Industry Stories

Top Industry Stories – May 3, 2010

Posted on May 3rd, 2010 | by Rxmedyn | No Comments »

Electronic Medical Orders May Save Lives

Long Lashes Without Prescription, but With Risks

Tylenol, Generics and Trust

Our Big Problem

Posted in Industry Stories